Antiproliferative and antimicrobial activities of pyrazolo[5,1- c][1,2,4]benzotriazine 5-oxides and their 5-deoxyderivatives

Medicinal Chemistry Research

Volumn 9, Issue 4, 1999, Pages 223-238

  Costanzo, A ^a   Ciciani, G ^a   Guerrini, G ^a   Bruni, F ^a   Selleri, S ^a   Donato, R ^a   Sacco, C ^a   Musiu, C ^b   Milia, C ^b   Longu, S ^b   Minnei, C ^b   La Colla, P ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,4 TRIAZINE DERIVATIVE; BENZOTRIAZOLE DERIVATIVE; MICONAZOLE; OFLOXACIN; PYRAZOLE DERIVATIVE; PYRAZOLO[5,1 C][1,2,4]BENZOTRIAZINE 5 OXIDE; STREPTOMYCIN; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CYTOTOXICITY; DRUG STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOBLASTOID CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

EID: 0032879903     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Reich, M.F.; Fabio, P.F.; Lee, V.J.; Kuck, N.A.; Testa, R.T. J. Med. Chem. 1989, 32, 2474-2485.
2. (a) Wolf, F.J.; Pfister, 3rd.; Wilson, R.M.; Robinson, C.A. J. Am.Chem.Soc. 1954, 76, 3551-3553.
3. (b) Horner, J.K.; Henry, D.W. J.Med. Chem. 1968, 11, 946-949.
4. (a) Baldwin R.W., Partridge M. W., Stevens M.F.G., J.Pharm.Pharmac. 1996, 18, Suppl., 1S-4S.
5. (b) Partridge M.W., Stevens M.F.G. J.Chem. Soc. (C) 1966, 1127-1131
6. Original Monograph-Drugs Fut. 1998, 23(3), 345-348.
7. Costanzo, A.; Guerrini, G.; Bruni, F.; Selleri, S. J. Heterocyclic Chem. 1994, 31, 1369-1376.
8. Guerrini, G.; Costanzo, A.; Bruni, F.; Selleri, S.; Casilli, M. L.; Martini, C.; Lucacchini, A.; Malmberg Aiello, P.; Ipponi A. Eur. J. Med. Chem 1996, 31, 259-272.
9. Guerrini, G.; Costanzo, A.,Bruni, F.; Ciciani, G.; Selleri,S.; Gratteri, P. " Benzodiazepine receptor ligands.III Synthesis, biological evaluation of 2-,3-substituted pyrazolo[5,1-c][1,2,4]benzotriazine 5-oxides" Il Farmaco 1999, in press.
10. (a) Palmer, B.D.; Wilson, W.R.; Anderson, R.F.; Boyd, M.; Denny, W.A. J. Med. Chem. 1996, 39, 2518-2528 and cited references.
11. (b) Edwards, D. I. In Comprehensive Medicinal Chemistry; Kennewell, P. D., Ed.; Pergamon: Oxford, 1990; Vol. 2, pp. 725-751.
12. Mai, A.; Artico, M.; Sbardella, G.; Quartatone, S.; Massa, S.; Loi, A. G.; De Montis, A.; Scintu, F.;Putzolu, M.; La Colla, P. J. Med. Chem. 1997, 40, 1447.
13. Pawels, R.; Balzarini, J.; Baba, M.; Snoeck, R.; Scholds, D.; Herdewijn, P.; Desmyter, J.; De Clercq, E. J.Virol. Methods 1988, 20, 309.
14. Peck, R. J. Immunol. Methods 1985, 82, 121.
15. Thom, S. M.; W.Horobin, R. W.; Seidler, E.; Barer, M. R. J. Appl. Bacteriol. 1993, 74, 433.